NCT07210047 2025-10-07Study of HuL001 in Relapsed/Refractory Multiple Myeloma PatientsHuniLife Biotechnology, Inc.Phase 1/2 Enrolling by invitation21 enrolled
NCT03628612 2025-08-07Long-term Follow-up of Patients Treated With Genetically Modified Autologous T CellsAutolus LimitedPhase 2 Enrolling by invitation500 enrolled